Literature DB >> 9789053

Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.

M Narazaki1, M Fujimoto, T Matsumoto, Y Morita, H Saito, T Kajita, K Yoshizaki, T Naka, T Kishimoto.   

Abstract

Cytokine-inducible protein SSI-1 [signal transducers and activators of transcription (STAT)-induced STAT inhibitor 1, also referred to as SOCS-1 (suppressor of cytokine signaling 1) or JAB (Janus kinase-binding protein)] negatively regulates cytokine receptor signaling by inhibition of JAK kinases. The SSI family of proteins includes eight members that are structurally characterized by an SH2 domain and a C-terminal conserved region that we have called the SC-motif. In this study, we investigated the roles of these domains in the function of SSI-1. Results of reporter assays demonstrated that the pre-SH2 domain (24 aa in front of the SH2 domain) and the SH2 domain of SSI-1 were required for the suppression by SSI-1 of interleukin 6 signaling. Coexpression studies of COS7 cells revealed that these domains also were required for inhibition of three JAKs (JAK1, JAK2, and TYK2). Furthermore, deletion of the SH2 domain, but not the pre-SH2 domain, resulted in loss of association of SSI-1 with TYK2. Thus, SSI-1 associates with JAK family kinase via its SH2 domain, and the pre-SH2 domain is required for the function of SSI-1. Deletion of the SC-motif markedly reduced expression of SSI-1 protein in M1 cells, and this reduction was reversed by treatment with proteasome inhibitors, suggesting that this motif is required to protect the SSI-1 molecule from proteolytic degradation. Based on these findings, we concluded that three distinct domains of SSI-1 (the pre-SH2 domain, the SH2 domain, and the SC-motif) cooperate in the suppression of interleukin 6 signaling.

Mesh:

Substances:

Year:  1998        PMID: 9789053      PMCID: PMC23734          DOI: 10.1073/pnas.95.22.13130

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.

Authors:  L E Marengere; T Pawson
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

2.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

Authors:  G Waksman; S E Shoelson; N Pant; D Cowburn; J Kuriyan
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

3.  A family of cytokine-inducible inhibitors of signalling.

Authors:  R Starr; T A Willson; E M Viney; L J Murray; J R Rayner; B J Jenkins; T J Gonda; W S Alexander; D Metcalf; N A Nicola; D J Hilton
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

Review 4.  Interleukin-6 family of cytokines and gp130.

Authors:  T Kishimoto; S Akira; M Narazaki; T Taga
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

Review 5.  Jaks and Stats in signaling by the cytokine receptor superfamily.

Authors:  J N Ihle; I M Kerr
Journal:  Trends Genet       Date:  1995-02       Impact factor: 11.639

6.  CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.

Authors:  A Matsumoto; M Masuhara; K Mitsui; M Yokouchi; M Ohtsubo; H Misawa; A Miyajima; A Yoshimura
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

Review 7.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

8.  Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation.

Authors:  K Yamamoto; F W Quelle; W E Thierfelder; B L Kreider; D J Gilbert; N A Jenkins; N G Copeland; O Silvennoinen; J N Ihle
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

9.  A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors.

Authors:  A Yoshimura; T Ohkubo; T Kiguchi; N A Jenkins; D J Gilbert; N G Copeland; T Hara; A Miyajima
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

10.  Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA.

Authors:  S Harroch; M Revel; J Chebath
Journal:  EMBO J       Date:  1994-04-15       Impact factor: 11.598

View more
  54 in total

1.  Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1.

Authors:  Daniela Ungureanu; Pipsa Saharinen; Ilkka Junttila; Douglas J Hilton; Olli Silvennoinen
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

2.  The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.

Authors:  Ping Wang; Ning Li; Jie-Shou Li; Wei-Qin Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome.

Authors:  Bao Q Vuong; Teresita L Arenzana; Brian M Showalter; Julie Losman; X Peter Chen; Justin Mostecki; Alexander S Banks; Andre Limnander; Neil Fernandez; Paul B Rothman
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

4.  The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.

Authors:  J G Zhang; A Farley; S E Nicholson; T A Willson; L M Zugaro; R J Simpson; R L Moritz; D Cary; R Richardson; G Hausmann; B T Kile; B J Kile; S B Kent; W S Alexander; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Salmonella pathogenicity island 2-dependent expression of suppressor of cytokine signaling 3 in macrophages.

Authors:  Kei-Ichi Uchiya; Toshiaki Nikai
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

6.  Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.

Authors:  Alicia S Chung; Ying-Jie Guan; Zheng-Long Yuan; Jorge E Albina; Y Eugene Chin
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.

Authors:  Rebecca A R Piganis; Nicole A De Weerd; Jodee A Gould; Christian W Schindler; Ashley Mansell; Sandra E Nicholson; Paul J Hertzog
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

8.  The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo.

Authors:  J G Zhang; D Metcalf; S Rakar; M Asimakis; C J Greenhalgh; T A Willson; R Starr; S E Nicholson; W Carter; W S Alexander; D J Hilton; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

9.  Mechanism of up-regulation of immunoglobulin A production in the intestine of mice unresponsive to lipopolysaccharide.

Authors:  Masahiro Kaneko; Yoshiyuki Akiyama; Hiroaki Takimoto; Yoshio Kumazawa
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

10.  Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse.

Authors:  Kohjiro Ueki; Tatsuya Kondo; Yu-Hua Tseng; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.